New Agents for Prevention of Ultraviolet-Induced Nonmelanoma Skin Cancer

Seminars in Cutaneous Medicine and Surgery

Volumn 30, Issue 1, 2011, Pages 6-13

  Camp, William L ^a   Turnham, Jennifer W ^a   Athar, Mohammad ^a   Elmets, Craig A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO N [4 CHLORO 3 (2 PYRIDINYL)PHENYL] 4 METHANESULFONYLBENZAMIDE; AMINOLEVULINIC ACID; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DEOXYRIBODIPYRIMIDINE PHOTOLYASE; DEOXYRIBONUCLEASE (PYRIMIDINE DIMER); EFLORNITHINE; EPIGALLOCATECHIN GALLATE; GENISTEIN; LYCOPENE; METHYLAMINOLEVULINATE; POLYPHENOL DERIVATIVE; PROTEIN P53; PROTEIN PATCHED 1; PROTOPORPHYRIN; PSORALEN; RETINOIC ACID; RETINOID; SONIC HEDGEHOG PROTEIN; SUNSCREEN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER PREVENTION; CHEMOPROPHYLAXIS; DNA DAMAGE; ERYTHEMA; FOOD INTAKE; FRUIT; HUMAN; IMMUNOMODULATION; LOW FAT DIET; NONMELANOMA SKIN CANCER; ORGAN TRANSPLANTATION; PHOTODYNAMIC THERAPY; PROTEIN PHOSPHORYLATION; PUVA; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; RADIATION INJURY; REVIEW; SKIN CANCER; SKIN PROTECTION; SQUAMOUS CELL CARCINOMA; TEA; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; UNSPECIFIED SIDE EFFECT; XERODERMA PIGMENTOSUM;

ANILIDES; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CAROTENOIDS; CELL TRANSFORMATION, NEOPLASTIC; CYCLOOXYGENASE 2 INHIBITORS; DIET, FAT-RESTRICTED; DNA REPAIR ENZYMES; EFLORNITHINE; FLAVONOIDS; GENISTEIN; HUMANS; KERATOSIS, ACTINIC; PHENOLS; PHOTOCHEMOTHERAPY; PYRIDINES; RETINOIDS; SKIN NEOPLASMS; SUNSCREENING AGENTS; ULTRAVIOLET RAYS;

EID: 79955397676     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2011.01.003     Document Type: Review

References (121)

1. Rogers H.W., Weinstock M.A., Harris A.R., et al. Incidence estimate of nonmelanoma skin cancer in the United States. Arch Dermatol 2010, 146:283-287.
2. Robinson J.K. Sun exposure, sun protection, and vitamin D. JAMA 2005, 294:1541-1543.
3. Gray D.T., Suman V.J., Su W.P., et al. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol Jun 1997, 133:735-740.
4. Christenson L.J., Borrowman T.A., Vachon C.M., et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005, 294:681-690.
5. Birch-Johansen F., Jensen A., Mortensen L., et al. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women. Int J Cancer 2010, 127:2190-2198.
6. Bickers D.R., Lim H.W., Margolis D., et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2006, 55:490-500.
7. Armstrong B.K., Kricker A. How much melanoma is caused by sun exposure?. Melanoma Res 1993, 3:395-401.
8. Demierre M.F. Time for the national legislation of indoor tanning to protect minors. Arch Dermatol 2003, 139:520-524.
9. Henriksen T., Dahlback A., Larsen S.H., et al. Ultraviolet-radiation and skin cancer. Effect of an ozone layer depletion. Photochem Photobiol 1990, 51:579-582.
10. Freeman R.G. Data on the action spectrum for ultraviolet carcinogenesis. J Natl Cancer Inst 1975, 55:1119-1122.
11. Mitchell D.L., Fernandez A.A., Nairn R.S., et al. Ultraviolet A does not induce melanomas in a Xiphophorus hybrid fish model. Proc Natl Acad Sci U S A 2010, 107:9329-9334.
12. Moan J., Dahlback A., Setlow R.B. Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation. Photochem Photobiol 1999, 70:243-247.
13. Setlow R.B., Regan J.D., German J., et al. Evidence that xeroderma pigmentosum cells do not perform the first step in the repair of ultraviolet damage to their DNA. Proc Natl Acad Sci U S A 1969, 64:1035-1041.
14. Gallagher R.P., Spinelli J.J., Lee T.K. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 2005, 14:562-566.
15. El Ghissassi F., Baan R., Straif K., et al. A review of human carcinogens-part D: Radiation. Lancet Oncol 2009, 10:751-752.
16. Rochette P.J., Therrien J.P., Drouin R., et al. UVA-induced cyclobutane pyrimidine dimers form predominantly at thymine-thymine dipyrimidines and correlate with the mutation spectrum in rodent cells. Nucleic Acids Res 2003, 31:2786-2794.
17. Kappes U.P., Luo D., Potter M., et al. Short- and long-wave UV light (UVB and UVA) induce similar mutations in human skin cells. J Invest Dermatol 2006, 126:667-675.
18. Mouret S., Philippe C., Gracia-Chantegrel J., et al. UVA-induced cyclobutane pyrimidine dimers in DNA: A direct photochemical mechanism?. Org Biomol Chem 2010, 8:1706-1711.
19. Gould J.W., Mercurio M.G., Elmets C.A. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol 1995, 33:551-573. quiz: 574-556.
20. Lankerani L., Baron E.D. Photosensitivity to exogenous agents. J Cutan Med Surg 2004, 8:424-431.
21. Stein K.R., Scheinfeld N.S. Drug-induced photoallergic and phototoxic reactions. Expert Opin Drug Saf 2007, 6:431-443.
22. Jensen A.O., Thomsen H.F., Engebjerg M.C., et al. Use of photosensitising diuretics and risk of skin cancer: A population-based case-control study. Br J Cancer 2008, 99:1522-1528.
23. Karagas M.R., Stukel T.A., Umland V., et al. Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: Results of a population-based case-control study. J Invest Dermatol 2007, 127:2901-2903.
24. Nishigori C. Cellular aspects of photocarcinogenesis. Photochem Photobiol Sci 2006, 5:208-214.
25. Melnikova V.O., Ananthaswamy H.N. Cellular and molecular events leading to the development of skin cancer. Mutat Res 2005, 571:91-106.
26. Mukhtar H., Elmets C.A. Photocarcinogenesis: Mechanisms, models and human health implications. Photochem Photobiol 1996, 63:356-357.
27. Buckman S.Y., Gresham A., Hale P., et al. COX-2 expression is induced by UVB exposure in human skin: Implications for the development of skin cancer. Carcinogenesis 1998, 19:723-729.
28. Pentland A.P., Schoggins J.W., Scott G.A., et al. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999, 20:1939-1944.
29. Rundhaug J.E., Fischer S.M. Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis. Photochem Photobiol 2008, 84:322-329.
30. Tripp C.S., Blomme E.A., Chinn K.S., et al. Epidermal COX-2 induction following ultraviolet irradiation: Suggested mechanism for the role of COX-2 inhibition in photoprotection. J Invest Dermatol 2003, 121:853-861.
31. Wang D., Dubois R.N. Prostaglandins and cancer. Gut 2006, 55:115-122.
32. Einspahr J.G., Xu M.J., Warneke J., et al. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses. Cancer Epidemiol Biomarkers Prev 2006, 15:1841-1848.
33. Derynck R., Akhurst R.J., Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001, 29:117-129.
34. Elmets C., Zepter K., Haffner A. The Role of cutaneous immunity in skin cancer. Skin Cancer 1995, 223-236. CRC Press, Boca Raton, FL. H. Mukhtar (Ed.).
35. Photoimmunology 1995, Blackwell Scientific, Oxford. J.T. Krutmann, C.A. Elmets (Eds.).
36. Ullrich S.E. Mechanisms underlying UV-induced immune suppression. Mutat Res 2005, 571:185-205.
37. Yoshikawa T., Rae V., Bruins-Slot W., et al. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 1990, 95:530-536.
38. Berg D., Otley C.C. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002, 47:1-17. quiz: 18-20.
39. Thompson S.C., Jolley D., Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993, 329:1147-1151.
40. Green A., Williams G., Neale R., et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: A randomised controlled trial. Lancet 1999, 354:723-729.
41. van der Pols J.C., Williams G.M., Pandeya N., et al. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006, 15:2546-2548.
42. Seukeran D.C., Newstead C.G., Cunliffe W.J. The compliance of renal transplant recipients with advice about sun protection measures. Br J Dermatol 1998, 138:301-303.
43. Faurschou A., Wulf H.C. The relation between sun protection factor and amount of suncreen applied in vivo. Br J Dermatol 2007, 156:716-719.
44. Norval M., Wulf H.C. Does chronic sunscreen use reduce vitamin D production to insufficient levels?. Br J Dermatol 2009, 161:732-736.
45. Diehl J.W., Chiu M.W. Effects of ambient sunlight and photoprotection on vitamin D status. Dermatol Ther 2010, 23:48-60.
46. Kraemer K.H., DiGiovanna J.J., Peck G.L. Chemoprevention of skin cancer in xeroderma pigmentosum. J Dermatol 1992, 19:715-718.
47. Moon T.E., Levine N., Cartmel B., et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: A randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev 1997, 6:949-956.
48. Nijsten T.E., Stern R.S. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: A cohort study. J Invest Dermatol 2003, 121:252-258.
49. Bavinck J.N., Tieben L.M., Van der Woude F.J., et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: A double-blind, placebo-controlled study. J Clin Oncol 1995, 13:1933-1938.
50. George R., Weightman W., Russ G.R., et al. Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients. Australas J Dermatol 2002, 43:269-273.
51. Kraemer K.H., DiGiovanna J.J., Moshell A.N., et al. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988, 318:1633-1637.
52. Lippman S.M., Meyskens F.L. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med 1987, 107:499-502.
53. Tangrea J.A., Edwards B.K., Taylor P.R., et al. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: A multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group. J Natl Cancer Inst 1992, 84:328-332.
54. De Graaf Y.G., Euvrard S., Bouwes-Bavinck J.N. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg 2004, 30:656-661.
55. Euvrard S., Verschoore M., Touraine J.L., et al. Topical retinoids for warts and keratoses in transplant recipients. Lancet 1992, 340:48-49.
56. Campanelli A., Naldi L. A retrospective study of the effect of long-term topical application of retinaldehyde (0.05%) on the development of actinic keratosis. Dermatology 2002, 205:146-152.
57. Smit J.V., Cox S., Blokx W.A., et al. Actinic keratoses in renal transplant recipients do not improve with calcipotriol cream and all-trans retinoic acid cream as monotherapies or in combination during a 6-week treatment period. Br J Dermatol 2002, 147:816-818.
58. Weinstock M.A., Bingham S.F., Lew R.A., et al. Topical tretinoin therapy and all-cause mortality. Arch Dermatol 2009, 145:18-24.
59. Hori N., Doi T., Karaki Y., et al. Participation of glutamic acid 23 of T4 endonuclease V in the beta-elimination reaction of an abasic site in a synthetic duplex DNA. Nucleic Acids Res 1992, 20:4761-4764.
60. Tanaka K., Sekiguchi M., Okada Y. Restoration of ultraviolet-induced unscheduled DNA synthesis of xeroderma pigmentosum cells by the concomitant treatment with bacteriophage T4 endonuclease V and HVJ (Sendai virus). Proc Natl Acad Sci U S A 1975, 72:4071-4075.
61. Wolf P., Yarosh D.B., Kripke M.L. Effects of sunscreens and a DNA excision repair enzyme on ultraviolet radiation-induced inflammation, immune suppression, and cyclobutane pyrimidine dimer formation in mice. J Invest Dermatol 1993, 101:523-527.
62. Yarosh D.B. Liposomes in investigative dermatology. Photodermatol Photoimmunol Photomed 2001, 17:203-212.
63. Yarosh D.B., O'Connor A., Alas L., et al. Photoprotection by topical DNA repair enzymes: Molecular correlates of clinical studies. Photochem Photobiol 1999, 69:136-140.
64. Yarosh D., Klein J., O'Connor A., et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: A randomised study. Xeroderma Pigmentosum Study Group. Lancet 2001, 357:926-929.
65. Gratchev A., Strein P., Utikal J., et al. Molecular genetics of xeroderma pigmentosum variant. Exp Dermatol 2003, 12:529-536.
66. Kraemer K.H., Lee M.M., Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987, 123:241-250.
67. Stege H. Effect of xenogenic repair enzymes on photoimmunology and photocarcinogenesis. J Photochem Photobiol B Biol 2001, 65:105-108.
68. Stege H., Roza L., Vink A.A., et al. Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci U S A 2000, 97:1790-1795.
69. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev 2001, 15:3059-3087.
70. Epstein E.H. Basal cell carcinomas: Attack of the hedgehog. Nat Rev Cancer 2008, 8:743-754.
71. Caro I., Low J.A. The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment. Clin Cancer Res 2010, 16:3335-3339.
72. Weiss G.J., Von Hoff D.D. Hunting the hedgehog pathway. Clin Pharmacol Ther Jun 2010, 87:743-747.
73. Rudin C.M. Beyond the scalpel: Targeting hedgehog in skin cancer prevention. Cancer Prev Res (Phila) 2010, 3:1-3.
74. Von Hoff D.D., LoRusso P.M., Rudin C.M., et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009, 361:1164-1172.
75. Pegg A.E. Regulation of ornithine decarboxylase. J Biol Chem 2006, 281:14529-14532.
76. Tang X., Kim A.L., Feith D.J., et al. Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice. J Clin Invest 2004, 113:867-875.
77. Gilmour S.K. Polyamines and nonmelanoma skin cancer. Toxicol Appl Pharmacol 2007, 224:249-256.
78. Bailey H.H., Kim K., Verma A.K., et al. A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer. Cancer Prev Res (Phila, PA) 2010, 3:35-47.
79. Alberts D.S., Dorr R.T., Einspahr J.G., et al. Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine. Cancer Epidemiol Biomarkers Prev 2000, 9:1281-1286.
80. An K.P., Athar M., Tang X., et al. Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: Implications for therapeutic approaches. Photochem Photobiol 2002, 76:73-80.
81. Arbiser J.L. Translating cyclooxygenase signaling in patch heterozygote mice into a randomized clinical trial in basal cell carcinoma. Cancer Prev Res (Phila) 2010, 3:4-7.
82. Tang J.Y., Aszterbaum M., Athar M., et al. Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/-humans and mice. Cancer Prev Res (Phila) 2010, 3:25-34.
83. Lee J.L., Mukhtar H., Bickers D.R., et al. Cyclooxygenases in the skin: Pharmacological and toxicological implications. Toxicol Appl Pharmacol 2003, 192:294-306.
84. Tjiu J.W., Chen J.S., Shun C.T., et al. Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol 2009, 129:1016-1025.
85. Tiano H.F., Loftin C.D., Akunda J., et al. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res 2002, 62:3395-3401.
86. Fischer S.M., Lo H.H., Gordon G.B., et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 1999, 25:231-240.
87. Fischer S.M., Pavone A., Mikulec C., et al. Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis. Mol Carcinog 2007, 46:363-371.
88. Tang J.Y., Aszterbaum M., Athar M., et al. Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/-humans and mice. Cancer Prev Res (Phila, PA) 2010, 3:25-34.
89. Elmets C.A., Singh D., Tubesing K., et al. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 2001, 44:425-432.
90. Katiyar S.K., Challa A., McCormick T.S., et al. Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis 1999, 20:2117-2124.
91. Katiyar S.K., Elmets C.A., Agarwal R., et al. Protection against ultraviolet-B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Photochem Photobiol 1995, 62:855-861.
92. Vayalil P.K., Mittal A., Hara Y., et al. Green tea polyphenols prevent ultraviolet light-induced oxidative damage and matrix metalloproteinases expression in mouse skin. J Invest Dermatol 2004, 122:1480-1487.
93. Wang J.M., Xu B., Rao J.Y., et al. Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur J Gastroenterol Hepatol 2007, 19:171-176.
94. Zheng W., Doyle T.J., Kushi L.H., et al. Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 1996, 144:175-182.
95. Wang Z., Agarwal R., Bickers D., et al. Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols. Carcinogenesis 1991, 12:1527-1530.
96. Mittal A., Piyathilake C., Hara Y., et al. Exceptionally high protection of photocarcinogenesis by topical application of (-)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: Relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia 2003, 5:555-565.
97. Vayalil P.K., Elmets C.A., Katiyar S.K. Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis 2003, 24:927-936.
98. Katiyar S.K., Afaq F., Perez A., et al. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 2001, 22:287-294.
99. Wei H., Bowen R., Zhang X., et al. Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Carcinogenesis 1998, 19:1509-1514.
100. Wei H., Zhang X., Wang Y., et al. Inhibition of ultraviolet light-induced oxidative events in the skin and internal organs of hairless mice by isoflavone genistein. Cancer Lett 2002, 185:21-29.
101. Wei H., Bowen R., Cai Q., et al. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 1995, 208:124-130.
102. Wang Y., Zhang X., Lebwohl M., et al. Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. Carcinogenesis 1998, 19:649-654.
103. Sarkar F.H., Li Y. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev 2002, 21:265-280.
104. Wei H., Saladi R., Lu Y., et al. Isoflavone genistein: Photoprotection and clinical implications in dermatology. J Nutr 2003, 133(suppl 1):3811S-3819S.
105. Moore J.O., Wang Y., Stebbins W.G., et al. Photoprotective effect of isoflavone genistein on ultraviolet B-induced pyrimidine dimer formation and PCNA expression in human reconstituted skin and its implications in dermatology and prevention of cutaneous carcinogenesis. Carcinogenesis 2006, 27:1627-1635.
106. Di Mascio P., Kaiser S., Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989, 274:532-538.
107. Fazekas Z., Gao D., Saladi R.N., et al. Protective effects of lycopene against ultraviolet B-induced photodamage. Nutr Cancer 2003, 47:181-187.
108. Stahl W., Sies H. Carotenoids and flavonoids contribute to nutritional protection against skin damage from sunlight. Mol Biotechnol 2007, 37:26-30.
109. Aoki H., Kieu N.T., Kuze N., et al. Carotenoid pigments in GAC fruit (Momordica cochinchinensis SPRENG). Biosci Biotechnol Biochem 2002, 66:2479-2482.
110. Stahl W., Sies H. Lycopene: A biologically important carotenoid for humans?. Arch Biochem Biophys 1996, 336:1-9.
111. Gartner C., Stahl W., Sies H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr 1997, 66:116-122.
112. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature. J Natl Cancer Inst 1999, 91:317-331.
113. Rizwan M., Rodriguez-Blanco I., Harbottle A., et al. Tomato paste rich in lycopene protects against cutaneous photodamage in humans in vivo: a randomized controlled trial. Br J Dermatol 2011, 164:154-162.
114. Black H.S., Herd J.A., Goldberg L.H., et al. Effect of a low-fat diet on the incidence of actinic keratosis. N Engl J Med 1994, 330:1272-1275.
115. Black H.S., Thornby J.I., Wolf J.E., et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. Int J Cancer 1995, 62:165-169.
116. Ibiebele T.I., van der Pols J.C., Hughes M.C., et al. Dietary fat intake and risk of skin cancer: A prospective study in Australian adults. Int J Cancer 2009, 125:1678-1684.
117. Davies T.W., Treasure F.P., Welch A.A., et al. Diet and basal cell skin cancer: Results from the EPIC-Norfolk cohort. Br J Dermatol 2002, 146:1017-1022.
118. Wulf H.C., Pavel S., Stender I., et al. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 2006, 86:25-28.
119. Wennberg A.M., Stenquist B., Stockfleth E., et al. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: A randomized study. Transplantation 2008, 86:423-429.
120. De Graaf Y.G., Kennedy C., Wolterbeek R., et al. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: Results of a randomized-controlled trial. J Invest Dermatol 2006, 126:569-574.
121. Willey A., Mehta S., Lee P.K. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Dermatol Surg 2010, 36:652-658.